CHEK2: Approximately one out of 40 northern Europeans have a mutation in this gene, making it a common mutation.
•
PALB2: Studies vary in their estimate of the risk from mutations in this gene.
cancer | American Cancer Society | Down syndrome | breast cancer | National Cancer Institute | Cancer Research UK | Cancer | Tourette syndrome | Asperger syndrome | Memorial Sloan-Kettering Cancer Center | Marfan syndrome | Gustav, Hereditary Prince of Sayn-Wittgenstein-Berleburg | Fred Hutchinson Cancer Research Center | Down Syndrome | colorectal cancer | Turner syndrome | Tropic of Cancer | prostate cancer | Macmillan Cancer Support | Ludwig Institute for Cancer Research | liver cancer | Fox Chase Cancer Center | Down's syndrome | Colorectal cancer | Asperger's syndrome | Williams syndrome | Teenage Cancer Trust | Stockholm syndrome | Severe acute respiratory syndrome | Rett syndrome |
BRCA mutation, mutations in two genes which produce a hereditary breast-ovarian cancer syndrome